Your browser doesn't support javascript.
loading
Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway.
Ando, Koji; Shah, Ankur K; Sachdev, Vibhu; Kleinstiver, Benjamin P; Taylor-Parker, Julian; Welch, Moira M; Hu, Yiheng; Salgia, Ravi; White, Forest M; Parvin, Jeffrey D; Ozonoff, Al; Rameh, Lucia E; Joung, J Keith; Bharti, Ajit K.
Afiliación
  • Ando K; Department of Medicine, Division of Hematology Oncology, Boston University School of Medicine, Boston, MA, USA.
  • Shah AK; Department of Medicine, Division of Hematology Oncology, Boston University School of Medicine, Boston, MA, USA.
  • Sachdev V; Department of Medicine, Division of Hematology Oncology, Boston University School of Medicine, Boston, MA, USA.
  • Kleinstiver BP; Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Taylor-Parker J; Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
  • Welch MM; Department of Medicine, Division of Hematology Oncology, Boston University School of Medicine, Boston, MA, USA.
  • Hu Y; Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Salgia R; Department of Biomedical Informatics, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • White FM; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte , CA, USA.
  • Parvin JD; Department of Biological Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Ozonoff A; Department of Biomedical Informatics, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Rameh LE; Center for Patient Safety and Quality Research, Boston Children's Hospital, Boston, MA, USA.
  • Joung JK; Department of Medicine, Obesity Research Center, Boston University School of Medicine, Boston, MA, USA.
  • Bharti AK; Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Oncotarget ; 8(27): 43733-43751, 2017 Jul 04.
Article en En | MEDLINE | ID: mdl-28415827
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Camptotecina / ADN-Topoisomerasas de Tipo I / Resistencia a Antineoplásicos / Ubiquitina / Complejo de la Endopetidasa Proteasomal / Inhibidores de Topoisomerasa I Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Camptotecina / ADN-Topoisomerasas de Tipo I / Resistencia a Antineoplásicos / Ubiquitina / Complejo de la Endopetidasa Proteasomal / Inhibidores de Topoisomerasa I Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos